Status:
TERMINATED
REMAP Trial for Optimizing Surgical Outcomes at UPMC
Lead Sponsor:
Matthew Neal MD
Collaborating Sponsors:
University of Pittsburgh Medical Center
Berry Consultants
Conditions:
Aging
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this project is to determine the effect of various interventions to improve patient outcome as defined by hospital free days at day 90 for adult patients undergoing elective surgery. Wi...
Eligibility Criteria
Inclusion
- UPMC REMAP
- Adult patient evaluated pre-operatively for elective surgery at UPMC
- Minimum lead time before surgery to provide domain specific intervention (range 7-180 days pre-operatively)
- Age greater to or equal to 18 years of age
Exclusion
- Death is deemed to be imminent or inevitable
- Emergency surgical procedure without suitable lead-in time
- Previous participation in this REMAP within the last 90 days, flagged by elective or emergency surgical encounter at UPMC in the past 90 days
- SPRY Domain
- Inclusion Criteria:
- Age \>= 60 years
- Age \< 60 but evidence of comorbidity risk as represented by a Charlson Comorbidity Index of \> 2 in 12 months prior to enrollment
- Able to take an oral medication in non-crushable pill form
- Women must be post-menopausal, which is defined as not having a menstrual period within the last 12 months
Key Trial Info
Start Date :
April 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 23 2022
Estimated Enrollment :
302 Patients enrolled
Trial Details
Trial ID
NCT03861767
Start Date
April 15 2019
End Date
September 23 2022
Last Update
June 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC
Pittsburgh, Pennsylvania, United States, 15213